Midway through trading Tuesday, the Dow traded up 1.25% to 34,429.02 while the NASDAQ rose 1.42% to 14,458.35. The S&P also rose, gaining 1.33% to 4,357.69.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 43,852,260 cases with around 703,280 deaths. India confirmed a total of at least 33,853,040 cases and 449,260 deaths, while Brazil reported over 21,478,540 COVID-19 cases with 598,150 deaths. In total, there were at least 235,472,580 cases of COVID-19 worldwide with more than 4,810,780 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Financials shares jumped 2.1% on Tuesday. Meanwhile, top gainers in the sector included Waterdrop Inc. (NYSE: WDH), up 6% and Silvergate Capital Corporation (NYSE: SI) up 9%.

In trading on Tuesday, real estate shares fell 1%.

Top Headline

PepsiCo, Inc. (NASDAQ: PEP) reported upbeat results for its third quarter and raised its FY21 organic revenue growth guidance.

PepsiCo reported quarterly adjusted earnings of $1.79 per share, beating analysts’ estimates of $1.73 per share. The company’s quarterly sales came in at $20.19 billion versus expectations of $19.39 billion.

PepsiCo boosted its FY21 organic revenue growth guidance from 6% to 8%.

Equities Trading UP

Agrify Corporation (NASDAQ: AGFY) shares shot up 9% to $20.13 after the company announced it acquired Precision Extraction Solutions and Cascade Sciences.

Shares of Shineco, Inc. (NASDAQ: TYHT) got a boost, shooting 12% to $11.73. Shineco agreed to acquire 51% equity interest of Beijing Wonner Biotech.

Zeta Global Holdings Corp. (NASDAQ: ZETA) shares were also up, gaining 18% to $7.43. Zeta reported the acquisition of the technology platform and data from Apptness.

Check out these big movers of the day

Equities Trading DOWN

UpHealth, Inc. (NYSE: UPH) shares tumbled 35% to $1.7050 after the company reported pricing of $40.25 million public offering of common stock.

Shares of Unity Biotechnology, Inc. (NASDAQ: UBX) were down 13% to $2.4315. UNITY Biotechnology reported 12-week data from Phase 1 clinical trial of UBX1325 in advanced vascular eye disease.

Kaleido Biosciences, Inc (NASDAQ: KLDO) was down, falling 11% to $5.18. Kaleido Biosciences announced positive topline data from the non-IND/CTA clinical study evaluating KB295, a microbiome metabolic therapy, in mild-to-moderate ulcerative colitis.

Commodities

In commodity news, oil traded up 2% to $79.18, while gold traded down 0.9% to $1,752.20.

Silver traded down 0.5% Tuesday to $22.540 while copper fell 1.1% to $4.1910.